US Stock MarketDetailed Quotes

SGHT Sight Sciences

Watchlist
  • 3.760
  • +0.030+0.80%
Close Nov 21 16:00 ET
  • 3.760
  • 0.0000.00%
Post 16:20 ET
190.84MMarket Cap-3722P/E (TTM)

About Sight Sciences Company

Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.

Company Profile

SymbolSGHT
Company NameSight Sciences
Listing DateJul 15, 2021
Issue Price24.00
Founded2010
CEOMr. Paul Badawi
MarketNASDAQ
Employees214
Fiscal Year Ends12-31
Address4040 Campbell Avenue,Suite 100
CityMenlo Park
ProvinceCalifornia
CountryUnited States of America
Zip Code94025
Phone1-877-266-1144
Websitehttp://www.sightsciences.com

Company Executives

  • Name
  • Position
  • Salary
  • Paul Badawi
  • Director, President and Chief Executive Officer
  • 3.90M
  • Alison Bauerlein
  • Principal Accounting Officer, Chief Financial Officer and Treasurer
  • 1.85M
  • Jeremy B. Hayden
  • Chief Legal Officer
  • --
  • Brenton Taylor
  • Executive Vice President, Operations and Chief Operating Officer
  • --
  • Matthew Link
  • Chief Commercial Officer
  • 2.36M
  • Dr. David Badawi, M.D.
  • Chief Technology Officer and Director
  • --
  • Dr. MK Raheja
  • Executive Vice President, Research and Development
  • --
  • Staffan Encrantz
  • Chairman of the Board
  • 207.91K
  • Brenda Becker
  • Independent Director
  • 167.33K
  • Dr. Tamara R. Fountain, M.D.
  • Independent Director
  • 401.06K
  • Donald J. Zurbay
  • Independent Director
  • 187.50K
  • Catherine Mazzacco
  • Independent Director
  • 256.34K
  • Erica J. Rogers
  • Independent Director
  • 182.30K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data